CBD Medication Epidiolex Receives a Positive Review from the FDA

It’s been some time since we started seeing news about a CBD (cannabidiol) based medicine  called Epidiolex being developed by the British company GW Pharmaceuticals. The marijuana-derived cannabinoid has proven useful in the treatment of seizures – and GW Pharmaceuticals has been conducting a drug trial using Epidiolex to treat two rare forms of intractable epilepsy, Dravet syndrome and Lennox-Gastaut syndrome (LGS), and the results of those trials are currently under review by the U.S. Food and Drug Administration (FDA) . If Epidiolex is approved by the FDA, then it will be one of the first cannabinoid-based medications –...

Read More